Orenstein Daniel H.
General Counsel
1 company
Insider Signal Score
84
ExcellentTrades Analyzed
13
12M Win Rate
92.3%
Avg 3M Return
+16.8%
Avg 12M Return
+59.2%
Orenstein Daniel H. serves as a General Counsel at HCAT. Across recent SEC filings that breaks down to 0 buys and 40 sells. Those positions are worth an estimated $226K at current prices.
Historically, Orenstein Daniel H.'s trades have earned a strong insider score of 84/100 across 13 rated trades. Over a 12-month horizon, 92.3% of those trades were profitable, with an average 12-month return of +59.2%.
The biggest single holding is HCAT (~$226K) as General Counsel. The recent filings there lean toward selling, a net 120,389 shares.
Holdings by Company
HCATMar 1, 2023
Current Shares133.1K
Value$226.3K
Net Activity-120,389
Bought: 0Sold: 120.4K
Transaction History
Showing 5 filings (page 3)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 500 | $37.01 | $18,505.00 | -1.2% | |
| Sep 15, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 5,000 | $35.69 | $178,444.78 | -5.8% | |
| Aug 14, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 5,000 | $31.45 | $157,250.00 | -11.1% | |
| Jul 15, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 5,000 | $36.16 | $180,801.79 | -5.7% | |
| Jun 19, 2020 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 10,000 | $32.00 | $320,000.00 | -20.0% |
← PrevPage 3